[1]
Bennison, C. et al. 2014. Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy. Farmeconomia. Health economics and therapeutic pathways. 15, 3 (Sep. 2014). DOI:https://doi.org/10.7175/fe.v15i3.944.